F
Francisco A. Tomás-Barberán
Researcher at Spanish National Research Council
Publications - 410
Citations - 42106
Francisco A. Tomás-Barberán is an academic researcher from Spanish National Research Council. The author has contributed to research in topics: Ellagic acid & Urolithin. The author has an hindex of 106, co-authored 389 publications receiving 36505 citations. Previous affiliations of Francisco A. Tomás-Barberán include Consiglio per la ricerca e la sperimentazione in agricoltura & University of Salamanca.
Papers
More filters
Journal ArticleDOI
Flavonoid content of commercial capers (Capparis spinosa, C. sicula and C. orientalis) produced in mediterranean countries
TL;DR: The flavonol content of commercial capers produced in different Mediterranean countries has been analysed and brining extracted most of the kaempferol 3-rhamnosyl rutinoside present in the original buds, this being a minor constituent in pickled capers.
Journal ArticleDOI
Intestinal Ellagitannin Metabolites Ameliorate Cytokine-Induced Inflammation and Associated Molecular Markers in Human Colon Fibroblasts
Juan Antonio Giménez-Bastida,Mar Larrosa,Antonio González-Sarrías,Francisco A. Tomás-Barberán,Juan Carlos Espín,María-Teresa García-Conesa +5 more
TL;DR: A combination of the ET metabolites found in colon, urolithins and EA, at concentrations achievable in the intestine after the consumption of pomegranate, was able to moderately improve the inflammatory response of colon fibroblasts and suggest that consumption of ET-containing foods has potential beneficial effects on gut inflammatory diseases.
Book ChapterDOI
Antioxidant phenolic metabolites from fruit and vegetables and changes during postharvest storage and processing
TL;DR: In this article, a review of the antioxidant activity of phenolic metabolites is presented, as well as their bioavailability, absorption and metabolism in animals and humans, and the changes in flavonoids and other phenolic antioxidants during the post-harvest life of fruit and vegetables are evaluated.
Journal ArticleDOI
Dietary phenolics against colorectal cancer--From promising preclinical results to poor translation into clinical trials: Pitfalls and future needs.
María Ángeles Núñez-Sánchez,Antonio González-Sarrías,María Romo-Vaquero,Rocío García-Villalba,María V. Selma,Francisco A. Tomás-Barberán,María-Teresa García-Conesa,Juan Carlos Espín +7 more
TL;DR: Overall, the clinical evidence of dietary phenolics against CRC is still weak and the amounts needed to exert some effects largely exceed common dietary doses, so the outlook and a roadmap to approach this topic are provided.
Journal ArticleDOI
Effects of ellagitannin‐rich berries on blood lipids, gut microbiota, and urolithin production in human subjects with symptoms of metabolic syndrome
Riitta Puupponen-Pimiä,Tuulikki Seppänen-Laakso,Matti Kankainen,Johanna Maukonen,Riitta Törrönen,Marjukka Kolehmainen,Tiina Leppänen,Eeva Moilanen,Liisa Nohynek,Anna-Marja Aura,Kaisa Poutanen,Kaisa Poutanen,Francisco A. Tomás-Barberán,Juan Carlos Espín,Kirsi-Marja Oksman-Caldentey +14 more
TL;DR: The results indicate that bioavailability of ellagitannins appears to be dependent on the composition of gut microbiota.